Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 juin 2009 10h06 HE | Source: Enobia Pharma Inc.

Enobia Announces Positive Interim Clinical Results With ENB-0040

MONTREAL, June 11, 2009 (GLOBE NEWSWIRE) -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that results from two early-stage...
11 juin 2009 10h06 HE | Source: Enobia Pharma Inc.

Experimental Drug Strengthens Bones in Infants With Severe Hypophosphatasia

Shriners Hospitals for Children's Dr. Michael Whyte Presents First Efficacy and Safety Results of Targeted Enzyme Replacement Therapy in Patients With Rare Genetic Bone Disease ...
19 mai 2009 09h58 HE | Source: Enobia Pharma Inc.

Enobia Pharma's ENB-0040 Receives FDA Fast Track Designation

MONTREAL, May 19, 2009 (GLOBE NEWSWIRE) -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that the U.S. Food and Drug...